Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
AD-109 by Apnimed for Obstructive Sleep Apnea: Likelihood of Approval
AD-109 is under clinical development by Apnimed and currently in Phase II for Obstructive Sleep Apnea. According to GlobalData, Phase...